Abstract
Febrile neutropenia (FN) frequently occurs after chemotherapy for hematological malignancies and is a potentially serious complication in this group of patients, as it increases the risk of septic shock. Despite advances in supportive care, gaps remain in our knowledge about the pathophysiology of sepsis complications in the context of FN. Furthermore, the association between neutropenia …